arrow
R

Robert Schmouder

novartis pharmaceuticals corporation
H指数:35
被引数:6,728

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical trial: A Phase 2 Randomised Platform Study to Assess Monotherapy and Combination Treatment Regimens in Metabolic Dysfunction-Associated Steatohepatitis

临床试验:一项评估代谢功能障碍相关脂肪性肝炎单药疗法和联合治疗方案的第2期随机平台研究

2025-11-012
OA
Multiple Supratherapeutic Doses of Iptacopan 400 Mg Twice Daily Are Well Tolerated in Healthy Participants: Safety Findings from a Randomized, Participant-Blinded, Placebo-Controlled, Phase I Study

400 mg 每日两次的多倍超治疗剂量伊塔可潘在健康受试者中耐受性良好:来自一项随机、受试者盲法、安慰剂对照的I期研究的 Safety 数据

BLOOD
IF23.1
2024-11-050
PRE
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
2023-02-0114
PRE
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events
2023-02-0115
PRE